Tuberkulosis Limfadenopati Paraaorta Abdomen pada Pasien Pasca Infeksi Covid-19: Sebuah Laporan Kasus
DOI:
https://doi.org/10.54259/sehatrakyat.v5i1.6016Kata Kunci:
Activated Latent TB, COVID-19, Extrapulmonary TuberculosisAbstrak
COVID-19 and tuberculosis (TB) remain major public health challenges in Indonesia, where the COVID-19 pandemic has disrupted TB prevention and control efforts, leading to decreased detection rates and increased mortality. Considering the coexistence of COVID-19 and TB in high-burden populations and the occurrence of post-COVID-19 tuberculosis cases, this report explores the potential activation of latent TB following COVID-19 infection. A 21-year-old female tested positive for SARS-CoV-2 by real-time PCR and was treated for COVID-19. Four weeks later, she developed persistent dry cough, epigastric discomfort, and night sweats. Radiological and hematological examinations revealed ground-glass opacities, lymphadenopathy, elevated inflammatory markers, and anemia. A positive IGRA test and paraaortic lymph node involvement confirmed extrapulmonary TB. The patient received nine months of antituberculosis therapy, resulting in complete resolution of lymphadenopathy. This case highlights a possible link between COVID-19 infection and the reactivation of latent TB, potentially triggered by immune dysregulation, cytokine storms, or T-cell depletion associated with SARS-CoV-2 infection. Clinicians should consider TB screening for post-COVID-19 patients exhibiting persistent or unexplained symptoms, particularly in TB-endemic regions, as early detection and treatment are essential to prevent severe complications and community transmission.
Unduhan
Referensi
Al-Kayali, R. S., Kashkash, M. F., Alhussein Alhajji, A. H., & Khouri, A. (2023). Activation of tuberculosis in recovered COVID-19 patients: A case report. Annals of Medicine and Surgery (2012), 85(2), 280–283. https://doi.org/10.1097/MS9.0000000000000188
Carvalho, V., Damasco, P. H., Mello, T. S., & Gonçalves, B. (2021). Para-aortic lymphadenopathy associated with adult COVID-19 multisystem inflammatory syndrome. BMJ Case Reports, 14(12), e246884. https://doi.org/10.1136/bcr-2021-246884
Cilloni, L., Fu, H., Vesga, J. F., & Dowdy, D. (2020). The potential impact of COVID-19 pandemic on tuberculosis epidemic: A modelling analysis. EClinicalMedicine, 28, 100603. https://doi.org/10.1016/j.eclinm.2020.100603
Diao, B., Wang, C., Tan, Y., et al. (2020). Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Frontiers in Immunology, 11, 827. https://doi.org/10.3389/fimmu.2020.00827
Friedman, A., & DeGeorge, K. C. (2022). Reactivation of latent tuberculosis in a COVID-19 patient on corticosteroid treatment. BMJ Case Reports, 15, e247562. https://doi.org/10.1136/bcr-2021-247562
Gembong Satria Mahardhika, Theodore Dharma Tedjamartono, & Prasetyo Widhi Buwono. (2021). High D-dimer and CRP levels in an asymptomatic COVID-19 patient: A case report and brief literature review. Seminar Nasional Riset Kedokteran, 2(1).
Iovino, M., Caruso, M., Corvino, A., et al. (2022). Latent tuberculosis reactivation in the setting of SARS-CoV-2 infection: The analysis of the radiologic features that help the diagnosis. Radiology Case Reports, 17(4), 1309–1312. https://doi.org/10.1016/j.radcr.2022.01.063
Jong, E. (2012). Extrapulmonary tuberculosis: A challenging diagnosis. Johannesburg: TB/HIV Symposium. Retrieved from http://www.anovahealth.co.za/images/uploads/ExtrapulmonaryTB-Jong.pdf
Kemenkes RI. (2020). Petunjuk teknis penanganan infeksi laten tuberkulosis (ILTB). Jakarta: Kementerian Kesehatan RI.
Kemenkes RI. (2021). Profil kesehatan Indonesia tahun 2020. Jakarta: Kementerian Kesehatan RI.
Kementerian Kesehatan Republik Indonesia. (2016). Buku petunjuk TB HIV bagi petugas kesehatan. Jakarta: Direktorat Pencegahan dan Pengendalian Penyakit, Kementerian Kesehatan RI.
Leonso, A.-A., Brown, K., Prol, R., Rawat, S., Khunger, A., & Bromberg, R. (2022). A rare case of latent tuberculosis reactivation secondary to a COVID-19 infection. Infectious Disease Reports, 14(3), 446–452. https://doi.org/10.3390/idr14030048
Mohammed, K., Hanan, F., & Yusuf, V. (2021). COVID-19 promoting the development of active tuberculosis in a patient with latent tuberculosis infection: A case report. Respiratory Medicine Case Reports, 34, 101344. https://doi.org/10.1016/j.rmcr.2021.101344
Rokom. (2022, March 22). Tahun ini, Kemenkes rencanakan skrining TBC besar-besaran. Kementerian Kesehatan RI. https://sehatnegeriku.kemkes.go.id/baca/rilis-media/20220322/4239560/tahun-ini-kemenkes-rencanakan-skrining-tbc-besar-besaran/
Surendra, H., Elyazar, I. R. F., Puspaningrum, E., Darmawan, D., Pakasi, T. T., Lukitosari, E., et al. (2023). Impact of the COVID-19 pandemic on tuberculosis control in Indonesia: A nationwide longitudinal analysis of programme data. The Lancet Global Health, 11(9). https://doi.org/10.1016/S2214-109X(23)00261-3
Tadolini, M., Codecasa, L. R., García-García, J. M., et al. (2020). Active tuberculosis, sequelae and COVID-19 co-infection: First cohort of 49 cases. European Respiratory Journal. https://doi.org/10.1183/13993003.01398-2020
WHO. (2021). Causes and symptoms: Global tuberculosis. World Health Organization.
Xie, J., Fan, H. W., Li, T. S., et al. (2006). Dynamic changes of T lymphocyte subsets in the long-term follow-up of severe acute respiratory syndrome patients. Chinese Academy of Medical Sciences Journal, 28(2), 253–255.
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet, 395(10229), 1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2026 Cecep Kurnia Suhayat, Nico Leonardy, Wardah Hanifah, Anita Chatrin
Artikel ini berlisensi Creative Commons Attribution 4.0 International License.
Hak cipta pada setiap artikel adalah milik penulis.
Penulis mengakui bahwa SEHATRAKYAT (Jurnal Kesehatan Masyarakat) sebagai publisher yang mempublikasikan pertama kali dengan lisensi Creative Commons Attribution 4.0 International License.
Penulis dapat memasukan tulisan secara terpisah, mengatur distribusi non-ekskulif dari naskah yang telah terbit di jurnal ini kedalam versi yang lain, seperti: dikirim ke respository institusi penulis, publikasi kedalam buku, dan lain-lain. Dengan mengakui bahwa naskah telah terbit pertama kali pada SEHATRAKYAT (Jurnal Kesehatan Masyarakat).
